The effect of supervised aerobic exercise on adipokine and myokine biomarkers in patients with cancer during systemic chemotherapy: a single-blinded prospective controlled trial
- 2 August 2025
- journal article
- research article
- Published by Springer Nature in Supportive Care in Cancer
- Vol. 33 (8) , 1-11
Abstract
Purpose This prospective study is aimed at assessing the effect of aerobic exercise on adipokine and myokine biomarkers of breast or colon cancer patients during chemotherapy. Methods Thirty-two patients (15 exercise, 17 control) were included in this study. In total, 27 out of 32 and 26 out of 32 patients were female and diagnosed with breast cancer, respectively. The exercise protocol was performed via stationary resistive cycle ergometer during chemotherapy 2 times each week for at least 12 weeks. Circulating serum biomarkers of IL-6, irisin, leptin, and adiponectin levels were measured before chemotherapy and after the last chemotherapy cycle. The intensity of exercise was set as submaximal (50–70% of heart rate reserve (HRR)). Each patient was started with the intensity of exercise at the rate of 50% of their maximal HR. Each supervised exercise session lasted for 35 min. Results The mean exercise duration (weeks) and percent adherence rates in the EG were 19.20 ± 3.63 weeks and 85.13 ± 11.87, respectively. In EG, there were significant increases in IL-6 (t = − 2.985, p = 0.011) and adiponectin (z = − 2.229, p = 0.026). Although a nearly 10% increase was observed in Irisin levels (0.83 vs. 0.91), it did not reach statistical significance (t = 0.840, p = 0.416). In EG, the correlation between Δ of leptin and adiponectin (r = − 0.635, p = 0.015) and the correlation between Δ of leptin and irisin (r = 0.802, p = 0.001) were found significant. No significant change was observed in each biomarker for CG. Conclusion This study demonstrated that aerobic exercise can be safely implementable and beneficial during chemotherapy with significant effects on anti-inflammatory biomarkers via increased levels of IL-6 and adiponectin. Trial registration. NCT07048847, date of registration: 02.07.2025, “retrospectively registered”.Keywords
Funding Information
- İzmir Bakırçay University Scientific Research Projects Coordination Unit (KBP-2022-009)
This publication has 55 references indexed in Scilit:
- The effects of exercise interventions on fatigue, body composition, physical fitness, and biomarkers in breast cancer patients during and after treatment: a systematic review and meta-analysis of randomized controlled trialsJournal of Cancer Survivorship, 2025
- Effect of exercise before and/or during taxane-containing chemotherapy treatment on chemotherapy-induced peripheral neuropathy symptoms in women with breast cancer: systematic review and meta-analysisJournal of Cancer Survivorship, 2023
- Effects and duration of exercise-based prehabilitation in surgical therapy of colon and rectal cancer: a systematic review and meta-analysisJournal of Cancer Research and Clinical Oncology, 2022
- The impact of high-intensity interval exercise training on NK-cell function and circulating myokines for breast cancer prevention among women at high risk for breast cancerBreast Cancer Research and Treatment, 2021
- Irisin Mediates Effects on Bone and Fat via αV Integrin ReceptorsCell, 2018
- Effects of Supervised vs. Unsupervised Training Programs on Balance and Muscle Strength in Older Adults: A Systematic Review and Meta-AnalysisSports Medicine, 2017
- Chronic Exercise Training and Circulating Irisin in Adults: A Meta-AnalysisSports Medicine, 2015
- Effects of the exercise‐inducible myokine irisin on malignant and non‐malignant breast epithelial cell behavior in vitroInternational Journal of Cancer, 2014
- Leptin and cancerJournal of Cellular Physiology, 2005
- REDUCTION IN SERUM IL-6 AFTER VACINATION OF BREAST CANCER PATIENTS WITH TUMOUR-ASSOCIATED ANTIGENS IS RELATED TO ESTROGEN RECEPTOR STATUSCytokine, 2000